Family Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,064
| Closed | -$167K | – | 240 |
|
|
2025
Q1 | $167K | Hold |
2,064
| – | – | 0.03% | 168 |
|
|
2024
Q4 | $186K | Sell |
2,064
-1,110
| -35% | -$100K | 0.03% | 154 |
|
|
2024
Q3 | $314K | Sell |
3,174
-3,247
| -51% | -$321K | 0.05% | 133 |
|
|
2024
Q2 | $595K | Sell |
6,421
-5,824
| -48% | -$540K | 0.1% | 90 |
|
|
2024
Q1 | $1.16M | Buy |
12,245
+2,592
| +27% | +$246K | 0.21% | 71 |
|
|
2023
Q4 | $862K | Buy |
9,653
+4,544
| +89% | +$406K | 0.18% | 69 |
|
|
2023
Q3 | $373K | Sell |
5,109
-825
| -14% | -$60.2K | 0.08% | 90 |
|
|
2023
Q2 | $494K | Buy |
5,934
+4,784
| +416% | +$398K | 0.11% | 81 |
|
|
2023
Q1 | $87.6K | Hold |
1,150
| – | – | 0.02% | 133 |
|
|
2022
Q4 | $95.5K | Buy |
+1,150
| New | +$95.5K | 0.02% | 149 |
|
|
2022
Q1 | – | Sell |
-7,009
| Closed | -$785K | – | 189 |
|
|
2021
Q4 | $785K | Buy |
7,009
+1,514
| +28% | +$170K | 0.2% | 81 |
|
|
2021
Q3 | $691K | Buy |
+5,495
| New | +$691K | 0.19% | 85 |
|
|
2020
Q4 | – | Sell |
-1,150
| Closed | -$128K | – | 178 |
|
|
2020
Q3 | $128K | Buy |
+1,150
| New | +$128K | 0.06% | 116 |
|
|
2020
Q2 | – | Sell |
-1,150
| Closed | -$89K | – | 180 |
|
|
2020
Q1 | $89K | Hold |
1,150
| – | – | 0.04% | 140 |
|
|
2019
Q4 | $109K | Hold |
1,150
| – | – | 0.04% | 162 |
|
|
2019
Q3 | $88K | Hold |
1,150
| – | – | 0.03% | 150 |
|
|
2019
Q2 | $101K | Buy |
+1,150
| New | +$101K | 0.04% | 143 |
|